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Although identified in the 1960’s, interest in autophagy has significantly increased in the past
decade with notable research efforts oriented at understanding as to how this multi-protein com-
plex operates and is regulated. Autophagy is commonly defined as a ‘‘self-eating” process evolved
by eukaryotic cells to recycle senescent organelles and expired proteins, which is significantly
increased during cellular stress responses. In addition, autophagy can also play important roles dur-
ing human diseases, such as cancer, neurodegenerative and autoimmune disorders. Furthermore,
novel findings suggest that autophagy contributes to the host defense against microbial infections.
In this article, we review the role of macroautophagy in antiviral immune responses and discuss
molecular mechanisms evolved by viral pathogens to evade this process. A role for autophagy as
an effector mechanism used both, by innate and adaptive immunity is also discussed.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Autophagy is a major cellular pathway involved in the degrada-
tion of decaying organelles and expired proteins inside eukaryotic
cells [1,2]. To date, three major autophagy pathways have been
described: macroautophagy, microautophagy and chaperone-
mediated autophagy [3]. In this review we will focus on macroau-
tophagy and refer to it as autophagy hereafter. Although autophagy
was initially described as a process carried out for the maintenance
of cellular homeostasis [1,2], accumulating studies have also pro-
vided data that associate alterations in autophagy componentswith
important diseases, such as neurodegenerative disorders, cancer,
chronic autoimmune-inflammatory syndromes and infectious dis-
eases [4,5]. Because a role for autophagy in pathogen control has
also been suggested by various studies, important research efforts
are currently being invested on better characterizing the contribu-
tion of this process to antiviral immunity. Indeed, autophagy has
been proposed to work as an intrinsic cell immune defense mecha-
nism against viral infections by targeting intracellular pathogens,such as viruses, for degradation [6]. Paradoxically, certain viruses
and other pathogens seem to rely on autophagy elements to repli-
cate and persist inside the host. Thus, viruses have evolved molec-
ular strategies to exploit and modulate the function of autophagy
components to use them for their benefit [7–11]. Some of these
findings are discussed below in this article.
2. The autophagy pathway
Autophagy is a process that requires the concerted assembly of
multiple proteins into molecular complexes that carry out sequen-
tial steps with defined functions [2]. The identification of autop-
hagy components was significantly advanced due to the use of
yeast genetic screening assays. Indeed, multiple autophagy-
related proteins (Atgs) have been identified using the yeast genetic
screening assay with further mammalian counterparts being
defined in other systems [12]. The major common physiological
activator of autophagy is starvation and growth factor deprivation
[2]. However, immune-inflammation signals can also lead to an
increase in autophagy [13], as well as the expression of several pro-
teins involved in this process (Fig. 1). mTOR, the mammalian target
of rapamycin, has been shown to be involved in the negative mod-
ulation of autophagy [14]. It is thought that mTOR keeps both,
Unc51-like kinase 1 (ULK1) and Atg13 in a hyperphosphorylated
Fig. 1. The autophagy pathway. In response to stimuli that promote autophagy, such as nutrient starvation or pathogen infection, mammalian target of rapamycin (mTOR)
dephosphorylates Unc51-like kinase 1 (ULK-1) and autophagy related protein 13 (Atg13), leading to the dissociation of mTOR from the ULK-1-Atg13-FAK family-interacting
protein of 200kD (FIP200) complex that together with the vacuolar protein sorting 34 (Vps34)-Atg14L-Beclin-1 complex favor nucleation of the membrane that will become
the autophagosome. Afterwards, autophagosome elongation and completion follows with the help of WD repeat domain phosphoinositide-interacting protein 1 (WIPI-1)-
Atg2, Atg9, Vps34 and the ubiquitin-like conjugations of Atg12-Atg5-ATG16L and Atg4B-Atg3-Atg7 complexes. Further, light chain 3 (LC3) precursor is cleaved by Atg4B to
produce the cytosolic form (LC3 I) and thereafter convert to membrane bound (LC3 II) – phosphatidylethanolamine (PE) conjugated through the activity of Atg7 and Atg3. The
Atg12-Atg5-ATG16L complex determines the sites for LC3 lipidation. Once the autophagosome is formed, it is fused with the lysosome to become autolysosome through
recruitment of the soluble N-ethylmaleimide-sensitive factor attachment (NSF) protein receptor (SNARE) proteins and its interaction with the homotypic fusion and vacuole
protein sorting (HOPS) and vesicle trafficking by GTPases. At the end, the components are trapped inside the autophagolysosome and degraded.
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200 kD (FIP200) complex [15]. Stimuli that promote autophagy,
such as nutrient starvation and pathogen infections, initiate
mTOR-mediated desphosphorylation of ULK-1 and Atg13, leading
to the dissociation of mTOR from the FIP200 complex [15]. Avibir-
navirus and human cytomegalovirus (hCMV) have been described
to induce autophagy in a mTOR-dependent manner [16,17]. MTOR
dephosphorylation activates autophagy, initiating the nucleation
of a cellular membrane (lipid bilayer) that will ultimately become
the autophagosome. This enveloping membrane has been named
as the ‘‘isolation membrane” or ‘‘phagophore” [18]. Importantly,
it has been proposed that the endoplasmic reticulum, the Golgi
apparatus and mitochondria may be the suppliers of lipid bilayers
that form the phagophore [19–21]. To promote the formation of
this membrane, the class III phosphoinositide-3-kinase (PIK3)
complex, which is composed of vacuolar protein sorting 34
(Vps34), Atg14 and Beclin-1, is recruited to the phagophore [18].
Indeed, Beclin-1 is a scaffolding protein for the regulation of the
PIK3 pathway [22]. Alternatively, the UV irradiation resistance-
associated gene (UVRAG) may induce this PI3K complex [23] and
promotes Atg9 trafficking [24]. Although Atg9 has been shown to
be essential for starvation-induced autophagy [25], the specific
function of this transmembrane protein remains somewhat
unknown. During the first steps of phagophore generation, Vps34
is recognized by the beta-transducin repeat domain (WD)
phosphoinositide-interacting protein 1 (WIPI-1), which cooperates
with Atg2 and Atg9 to form of this structure [26]. These events
trigger a downstream Atg conjugation system, which regulates
autophagosome elongation [18].
Subsequently, autophagosome formation is catalyzed by two
ubiquitin-like conjugation systems: the Atg12-Atg5-ATG16L andAtg4B-Atg3-Atg7 complexes [27,28]. As part of this process, light
chain 3 (LC3) precursor is cleaved by Atg4B to produce a cytosolic
form (LC3 I) and later converted into a membrane-bound form (LC3
II), which is conjugated with phosphatidylethanolamine (PE)
through the activity of Atg7 and Atg3 [29–31]. The Atg12-Atg5-
ATG16L complex in turn acts as an E3-like enzyme and determine
particular sites for LC3 lipidation [32]. Gamma-aminobutyric acid
receptor-associated protein (GABARAP) and Golgi-associated
ATPase enhancer of 16kDa (GATE-16) are homologs of LC3 and
are involved in the late stages of autophagosome maturation
[33]. P62 (also known as the sequestosome, SQSTM1) and the
curvature-driving protein (Bif-1) are ubiquitination-binding
proteins that contribute also to this maturation process [34].
Bif-1 also interacts with Beclin-1 through UVRAG as a positive
regulator, aiding to autophagosome formation [35]. Importantly,
conversion from LC3-I to LC3-II has been extensively used as a
marker of autophagy [36–40]. Concomitantly, because p62 accu-
mulates when autophagy is inhibited, this protein has also been
used as an autophagic flux marker [41]. Once the autophagosome
is formed, it fuse with the lysosome to form the autolysosome
through the recruitment of the soluble N-ethylmaleimide-
sensitive factor attachment (NSF) protein receptor (SNARE), pro-
tein syntaxin 17 (Stx17) and interact with the homotypic fusion
and vacuole protein sorting (HOPS) complex [42,43]. HOPS is a
class-C Vps complex which is composed by Vps11, Vps16, Vps18,
Vps33, Vps39 and Vps41. The vesicle trafficking process that occurs
during this fusion is regulated by GTPases such as Ras superfamily
of monomeric G protein (Rab) 7, Rab8b and Rab24 [44]. At the end
of the process, specific components, such as decaying organelles
and expired proteins are trapped inside the autophagolysosome
and degraded [1].
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3.1. Virus recognition
Toll-like receptors (TLRs), nucleotide-binding oligomerization
domain (NOD)-like receptors (NLRs) and Retinoic acid-inducible
gene (RIG-1)-I-like receptors (RLRs) are the pattern recognition
receptors (PRR) involved in detecting pathogen components, such
as single- and double-stranded viral RNAs [45,46]. Several TLRs
are known to activate innate responses after virus infection,
including TLR2, TLR3, TLR4, TLR7 and TLR8 [45,46]. TLR2 and
TLR4 are expressed on the cell surface whereas TLR3, TLR7 and
TLR8 are localized within cytoplasmatic compartments, such as
endosomes [47–49]. TLR activation within endosomes requires
endocytosis of pathogen associated molecular patterns (PAMPs),
such as viral RNA molecules, damage associated molecular pat-
terns (DAMPs), apoptotic cells or the induction of autophagy
[50,51]. Several viruses can evade immediate recognition by TLRs
after entering cells through endosome-associated compartments,
thereby delaying the onset of an immune response [50]. TLR signal-
ing results in the activation of nuclear factor kappa B (NF-jB),
interferon regulatory transcription factor (IRF)-3 and IRF-7 and
the assembly of inflammasome to activate caspase-1 and further
process pro-interleukin (IL)-1b and IL-18 into their active forms
[52]. Upon viral RNA detection, cytosolic PRRs, for instance
Nod domain 2 (Nod2), RNA helicases such as melanoma
differentiation-association gene-5 (MDA5), and RIG-I are activated
[53]. RIG-I interacts with the adaptor interferon (IFN)-b promoter
stimulator (IPS-1; also known as MAVS, VISA or CARDIF) on the
mitochondrial membrane, and consequently activates the tran-
scription factors IRF-3 and NF-jB, leading to the production ofFig. 2. Autophagy and antiviral innate immunity. Viruses may enter cells by endocytosis
can be recognized by Toll-like receptor 3 (TLR3) and ssRNA by TLR7 or TLR8, triggering in
receptor associated receptor 6 (TRAF6) followed by Type I interferon (IFN) production.
lysosomes. Herpes simplex virus 1 (HSV-1), influenza virus, human immunodeficiency vir
blocking Beclin-1. The phagosome-lysosome fusion induces activation of interferon regul
of retinoic acid-inducible gene-1 (RIG-I), nucleotide-binding oligomerization domain (NO
adaptor IFNP promoter stimulator (IPS-1) on the mitochondrial membrane triggering acti
by Atg12-Atg5 complex. The mitochondrial cascade triggers induction of NOD-like re
caspase-1-mediated IL-1b production. IRF3 and IRF7 are transcription factors of type-I IIFN-b and other cytokines (Fig. 2). IPS-1 has been shown to con-
tribute to the type-I IFN-mediated mechanisms of antiviral host
defense [50]. This notion is supported by the observation that
IPS-1-knockout mice show an increased recruitment of inflamma-
tory neutrophils, monocytes and dendritic cells (DCs) in the lungs
after human respiratory syncytial virus (hRSV) infection [50], evi-
dencing the importance of this adaptor in antiviral responses for
the clearance of hRSV. The papain-like protease 2 (PLP2) protein
from coronaviruses promotes Beclin-1 association with STING
[10]. Another protein that has been shown to regulate autophagy
and the antiviral defense is Tripartite motif protein family (TRIM)
[54], which blocks IRF-3/7 via serine/threonine protein kinase
(TBK1) and NF-jB [55]. In addition, TRIMs associate with autop-
hagy factors. Indeed, TRIM5 was found to recognize and target
human immunodeficiency virus 1 (HIV-1) for destruction [56].
3.2. Innate immunity components and autophagy-related proteins
Molecular components related to autophagy have been fre-
quently described to contribute to the replication of certain viruses
[57–59]. Indeed, RIG-1 has been described to be modulated by Atgs
activated by viruses, such as vesicular stomatitis virus (VSV) [57].
For instance, embryonic fibroblasts from Atg5-deficient mouse
were shown to be resistant to VSV replication, suggesting that
autophagy components can contribute to viral replication in host
cells. The constitutive overexpression of a mutant of RIG-1 induced
the activation of NF-jB and IFN-b, which was suppressed by the
co-expression of the Atg5-Atg12 complex [57]. This suppression
seemed to be dependent on infection with VSV and was reported
to induce a conformational change in RIG-1 [57]. Nucleotide-
binding domain and leucine-rich-repeats containing proteinsresulting in the delivery of viral RNA in the endosome. Once in the endosome, dsRNA
terleukin 1 (IL-1) receptor associated kinase (IRAK) and tumor necrosis factor (TNF)
Cytosolic RNA can also trigger autophagosome formation followed by fusion with
us and viruses from Coronaviridae have been shown to inhibit autophagy by directly
atory factor 7 (IRF7) via TLR7. Autophagy can be triggered by the cytosolic presence
D) or melanoma differentiation-association gene 5 (MDA5). RIG-I interacts with the
vation of IRF3/7 and nuclear factor kappa B (NF-jB). This interaction can be blocked
ceptor family pyrin domain-containing 3 (NLRP3) inflammasome, which triggers
FN and NF-jB of proinflammatory cytokines.
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factor (TUFM) in turn have been shown to modulate autophagy
via RIG-1 signaling and activation of IFN-I, as well as the associa-
tion with the Atg5-Atg12 complex and ATG16L [60]. The induction
of autophagy by NLRX1 was specifically shown in VSV-infected
peritoneal macrophages from nlrxl knockout mice [60]. Similarly,
it was shown that IFN-b-induced phagosomes were directed to
lysosomes for degradation in hepatitis B virus (HPV) infection in
a non-structural serine protease 3(NS3)/4A transgenic mouse
model [61].
Inhibition of Nod-dependent response by ATG16L has also been
described in mouse embryonic fibroblasts and epithelial cells [62].
Nod1, Nod2 have been shown to colocalize with ATG16L and Nod2
to trigger autophagy by recruiting ATG16L at the site of pathogen
entry [63]. TLR4 recognition via tumor necrosis factor (TNF)
receptor-associated factor (TRAF) also induces the K63-linked
ubiquitination of Beclin-1, triggering autophagy as well as blocking
the inhibitor of autophagy anti-apoptotic B-cell lymphoma 2
(Bcl-2) [64]. Thus, the Atg5-Atg12 complex, ATG16L and Beclin-1
all autophagy-related proteins that have been reported to interact
with components of the innate immune system.
3.3. Autophagy and inflammatory cytokines
Viruses have evolved several molecular strategies to evade
antiviral host responses, such as modulation of inflammatory cyto-
kines. Recently, it was shown that a lack of Atg5 in dendritic cells
(DCs) infected with herpes simplex virus (HSV), resulted in reduced
IFN-b production [65]. Autophagy has also been shown to be impor-
tant for the production of cytokines produced from innate immune
cells. Indeed, blockade of autophagy by the 3-methyladenine (3-
MA) inhibitor in DCs infectedwith hRSV has been shown to prevent
the expression of interferons, chemokines and cytokines, such as
IFN-b, TNF-a, C-C motif ligands 5 (CCL5), IL-6, and IL-12p35, but
not IL-1b [66]. Furthermore, knock-out of Beclin-1 resulted in
increased lung pathology in hRSV-infected mice [67].
An association between autophagy and lung inflammation with
other viruses, different than hRSV has also been described. Consis-
tent with this notion, autophagy has been shown to be involved in
avian influenza A virus (IAV)-induced lung inflammation [68].
Influenza A virus subtype H5N1 infection induces IL-1b, TNF-a,
IL-6, IL-8, and CCL2, CCL5 and C-X-C motif ligand 2 (CXCL2)
chemokines. Treatment with the autophagy inhibitor 3-MA or
either Atg5 or Beclin-1 siRNA, significantly reduced the production
of cytokines and chemokines as well as the nuclear translocation of
NF-jB in human lung epithelial cells [68]. Interestingly, the
administration of the autophagy inhibitor 3-MA to H5N1-
infected mice resulted in an attenuation of lung inflammation, as
well as the activation of NF-jB and p38 mitogen-activated protein
kinases (MAPK) [68].4. Autophagy and antiviral adaptive immunity
4.1. Autophagy in antigen presentation
In addition to playing a role during innate immune responses to
virus infections, autophagy also contributes to the regulation of
adaptive immune responses against these and other pathogens.
For instance, autophagy contributes to antigen presentation to T
cells by antigen presenting cells and is required for an effective
initiation of the adaptive immune response [11,67,69]. Indeed, pre-
sentation of pathogen-derived peptides on major histocompatibil-
ity complex (MHC) class II molecules to CD4+ T cells has been
reported to be facilitated by autophagy [70] (Fig. 3). Antigen
acquired by phagocytosis will be degraded into peptides by theautophagosome and eventually loaded onto MHC molecules [71].
The peptide-MHC (pMHC) complexes generated are then trans-
ported to the cell surface and presented to CD4+ T cells. In contrast
to antigen presentation on MHC-II molecules, antigen presentation
on MHC-I molecules can be mediated by two pathways in which
only one involves autophagy. During conventional MHC-I antigen
presentation, endogenous protein antigens are degraded into pep-
tidic fragments by the proteasome and then transported into the
endoplasmic reticulum, where they are translocated to the lumen
through the transporter associated with antigen processing (TAP)
[71]. Once in the endoplasmic reticulum, peptides are loaded onto
MHC-I molecules and then transported to the surface for presenta-
tion to CD8+ T cells [71]. It has been suggested that the alternative
pathway for antigen presentation on MHC-I molecules, called
cross-presentation, may require autophagy components [72–74].
Cross-presentation consists on the presentation of exogenous anti-
gens on MHC I molecules to CD8+ T cells [71]. This pathway has
been reported practically in every type of immune response, such
as tumor immunity [74], autoimmunity [75] and microbial infec-
tions, such as in macrophage infection by HSV-1 [72], as well as
DCs stimulated with the yellow fever vaccine [73]. Furthermore,
it has been shown that viral proteins undergo vacuolar processing
in autophagosomes, which is followed by proteasome degradation
and peptide loading on MHC-I molecules in the endoplasmic retic-
ulum [72]. However, the molecular mechanisms involved in vacuo-
lar processing of viral proteins remains unknown.
4.2. Evasion of autophagy mediated antigen presentation by viral
pathogens
Because of the importance of antigen presentation on MHC
molecules for virus clearance by the host immune response, patho-
gens have evolved molecular mechanisms to evade this process.
Along these lines, it has been shown that human hepatitis virus
C (HVC) reduces cathepsin S through IRF-1 and upstream stimula-
tory factor (UPS-1), thereby altering the degradation of the invari-
ant chain and consequently antigen presentation [76]. Similarly,
LC3-deficient DCs show a significant impairment in their capacity
to present HIV-1-derived antigens to CD4+ T cells [69]. Epstein-
Barr virus nuclear antigen 1 (EBNA-1) has been shown to inhibit
autophagy, thereby decreasing recognition by EBNA-1-specific
CD4+ T cell clones [77]. An association between autophagy and
adaptive immunity is suggested by observation that Atg5-
deficient DCs fail at presenting antigens on MHC class II molecules,
as well as at priming and promoting the proliferation of T cells
in vivo after HSV infection [65]. However, abrogation of Atg5 in
DCs had no effect on antigen cross-presentation on MHC class I
molecules, suggesting that Atg5 is not essential for this pathway
[65]. Interestingly, phagosomes coated with LC3 protein maintain
antigens for prolonged periods of time, favoring antigen presenta-
tion on MHC class II molecules [78]. Recently, a Beclin-1+/ mouse
showed that loss of autophagy function could lead to decreased
MHC-II expression after hRSV infection and failure to produce
IFN-c and IL-17, thereby impairing both DC maturation, as well
as the onset of an effective antiviral adaptive immune response
against this virus [67]. Furthermore, the expression of granzyme
B in CD8+ T cells has been shown to be decreased in Beclin-1+/
mice [67].
4.3. Therapeutic strategies to improve antigen presentation
Due to the fact that weak CD4+ T cell-mediated responses have
been observed in more than one HIV vaccine clinical trial [79,80],
Jin and coworkers [81] designed a recombinant simian immunod-
eficiency virus expressing Gag fused to LC3b. Such a construction
caused that Gag localizes to the autophagosome and lysosomes,
Fig. 3. Autophagy and antiviral adaptive immunity. (1) Major histocompatibility complex (MHC) II antigen presentation. Antigen is captured by phagocytosis, degraded by
the autophagosome and then loaded onto MHC molecules in the late endosomal MHC compartment and eventually peptide-MHC complexes trafficked to be presented to
CD4+ T cells. (2) Conventional MHC I antigen presentation. Endogenous antigen is degraded into peptides fragments in proteosomes, transported to the endoplasmic
reticulum via antigen processing (TAP), loaded into MHC class I molecule and then transported to the surface to be presented to CD8+ T cells. (3) Antigen cross presentation on
MHC-I. Autophagy is suggested to be involved in exogenous antigen processing but its mechanism is unknown. In cells infected with respiratory syncytial virus (RSV), herpes
simplex virus (HSV)-1, HSV-2 and human immunodeficiency virus, autophagy have been shown to be important for antigen presentation on MHC class II molecules. Vacuolar
viral proteins processing has been reported for Epstein-Barr virus nuclear antigen 1 (EBNA1) and HSV-1.
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was shown to significantly improve the immunogenicity of HIV
antigens and the induction of an adaptive immune responses upon
infection [81]. Along these lines, other novel strategies have been
undertaken to enhance antigen presentation and immune response
induction. For instance, a peptide derived from HSV that induces
autophagosomal degradation of antigens was implemented to pro-
tect from tumor challenge [82]. Such a peptide could be attached to
antigenic viral proteins for vaccine design, as a manner to enhance
immunogenicity. However, as noted above not all autophagy
proteins are essential for antigen presentation, as Atg7-deficient
thymocytes and DCs showed no alterations in any antigen presen-
tation pathway for exogenous or endogenous antigens [83]. Taken
together, these studies provide an important link between antigen
presentation of virus-derived proteins and the autophagosome
function in antigen presenting cells. Ultimately, modulating autop-
hagy during infection could improve the overall immune response
to pathogens.
5. Autophagy exploitation by viruses to evade host immunity
Autophagy is critical for limiting infection by pathogens [84,85].
However, some microorganisms, such as coronavirus, HIV
and cytomegalovirus have developed mechanisms to evade thismicrobicide system [13,86,87]. Numerous evasion mechanisms
evolved by these microbes have been associated with the inhibi-
tion of autophagosome-lysosome fusion, escape from phagocytic
vacuoles in the cytoplasm and resistance to lysosome degradation
components. Indeed for antiviral responses, an important role for
autophagy has been shown in several virus infections (Table 1).
5.1. Autophagosome-lysosome fusion modulation by viruses
HSV-1, influenza virus, HIV, HCV and coronavirus are all able to
induce autophagy. However, at the same time these viruses have
been shown to inhibit the last step of autophagosome-lysosome
fusion, which promotes viral replication and reduces cell apoptosis
or death [7–11]. HSV-1 induces autophagy in such a way that it
antagonizes autophagosome maturation by the interaction of
HSV c34.5 protein with Beclin-1 [7]. It has been suggested that
an inefficient fusion between autophagosomes and lysosomes in
HSV-infected cells is induced by oxidative stress and has been
associated with neurodegeneration [88]. In addition, c34.5 has
been shown to be important for HSV virulence in the brain of adult
and neonatal animals and dependent on type-I IFN only in adults
[89]. HCV has also been reported to induce autophagy and endo-
plasmic reticulum stress, leading to an accumulation of autophago-
somes that require the activation of the unfolded protein response
Table 1
Interactions of various viruses with the autophagy pathway.
Virus Interactions viruses with autophagy machinery Viral proteins
involved
Autophagy
related
proteins
References
Herpes Simplex Virus 1
(HSV-1)
HSV-1 triggers autophagy but inhibit autophagosome-lysosome fusion,
autophagosomes are accumulated
c34.5 protein Beclin-1,
Atg5
[7,65]
Influenza virus Influenza induces autophagy but inhibit autophagosome-lysosome fusion,
autophagosomes are accumulated
Matrix protein 2
(MP2)
LC3, Atg5 [8,39]
Human immunodeficiency
virus (HIV)
HIV triggers autophagy but inhibit autophagosome-lysosome fusion,
autophagosomes are accumulated in CD4+ T cells while HIV interferes in
autophagosome-mediated degradation
Nef protein Beclin-1 [9,101,102]
Coronaviridae family Viruses from Coronaviridae family trigger autophagy but inhibit autophagosome-
lysosome fusion, autophagosomes are accumulated. Autophagy is critical for
virus replication
Membrane-
associated papain-
like protease PLP2
(PLP2-TM)
Beclin-1, LC3 [10,103]
Vesicular stomatitis virus
(VSV)
Autophagy in plasmacytoid dendritic cells are required for VSV recognition and
autophagy is required for virus replication
Unknown Atg5 [65]
Sindbis virus Sindbis virus induces autophagy and overexpression autophagy proteins protects
from infection
Capside protein p62, Atg7,
Atg5
[58,59]
Human respiratory
syncytial virus (hRSV)
Beclin /+ mice show higher levels Th2, lower IFN and IL17, decrease expression
granzyme B in CD8+ T cells and increased viral replication
Unknown Beclin-1 [50,67]
Human hepatitis virus C
(HVC)
HVC induces autophagy and ER stress, and autophagosomes are accumulated.
HVC core and NS5A proteins reduce expression cathepsin S which is involved in
the degradation of the autophagy cargo
HVC core and NS5A UPR [11,76,90,91]
Human hepatitis virus B
(HVB)
HVB triggers autophagy favoring replication of DNA HVB, the production of viral
envelopment and release of naked capsides
Unknown Unknown [115–117]
Cytomegalovirus Cytomegalovirus induces autophagy in early stages but inhibits it in late stages TRS protein Beclin-1 [36–38]
Varizella-zoster (VZV) VZV triggers complete autophagy which facilitate VZV glycoproteins biosynthesis
and processing
Unknown Unknown [92]
Measles (MeV) MeV increases autophagy flux Unknown LC3 [93]
Adenovirus Adenovirus is more efficiently replicated in cells with induced autophagy Unknown Unknown [97]
Simian immunodeficiency
virus type I (SIV)
SIV inhibits neuronal autophagy Unknown Unknown [109]
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been reported to block autophagy in differentiating monocytes
suggesting the participation of soluble components in sera with
this particular capacity [11]. In contrast, varicella-zoster virus
(VZV) promotes a complete autophagy process, which has been
evidenced by the degradation of some of its long-lived proteins
[92]. Autophagy in this latter case seems to be used by the virus
to facilitate VZV glycoprotein biosynthesis and processing [92].
Similar to VZV, measles virus (MeV) increases autophagy but
prevents the degradation of viral proteins [93]. Interestingly,
MeV-induced autophagy is required for the replication of the virus.
In addition, enteroviruses, such as coxsackievirus and rotavirus
have also been reported to interact with autophagy elements to
evade immunity by increasing respectively protein- and calcium-
activated signaling in infected cells [94–96]. Another example of
virus exploitation of the autophagy machinery is provided by ade-
noviruses [97]. These pathogens replicate more efficiently in the
airways when epithelial cells undergo nutrient deprivation-
induced autophagy [97]. The mechanisms used by other viruses
that induce autophagy, such as dengue and parvovirus B19 remain
to be undetermined [98,99].
5.2. Viral proteins interacting with autophagy-related proteins
An extended two-hybrid array, with 35 associated autophagy
proteins and 80 different viral proteins from 5 different families
of RNA viruses (Paramyxoviridae, Flaviviridae, Orthomyxoviridae,
Togaviridae and Retroviridae), showed that these viruses targeted
several autophagy proteins [100]. Among these proteins,
immunity-associated GTPase family M (IRGM) was a common tar-
get for all the viruses studied [100]. Importantly, autophagosome
accumulation due to the inhibition of autophagosome-lysosome
fusion in MeV, HCV and HIV was shown to be IRGM-dependent
by confocal microscopy [100]. In addition, it is likely that IRGM
can modulate initial autophagy steps because this moleculetargeted Atg5, Atg10 and LC3, all components of the initial phase
of autophagy [100].
Viral c34.5 protein from HSV-1 [7], Nef protein from HIV
[9,101,102], non-structural protein 3 from coronavirus [10] and
matrix protein 2 (M2) protein from influenza viruses [8] have been
shown to interact with Beclin-1, thereby modulating the function
of autophagy. PLP2 from coronaviruses induces an incomplete
autophagy process by interacting with LC3 and Beclin-1 [10]. In
addition, the deletion of Beclin-1 has been shown to activate
IFN-b promoter and increase viral replication in infected
coronavirus cells [10]. Alternatively, non-structural protein 6
(Nsp6) from viruses belonging to the Coronaviridae family induces
LC3-positive vesicles.
5.3. Autophagy in different cell types infected with viruses
On the other hand, the mouse hepatitis coronavirus (hCMV),
induces autophagy in murine embryonic stem cells, which is criti-
cal for the replication of the virus [103]. In contrast, Atg5 was not
required for mHPV replication in both primary bone marrow
macrophages and primary low-passage mouse embryonic fibrob-
lasts [104]. Therefore, it is likely that this virus may be interacting
differently with the autophagy components depending on the cell
type encountered. Similar to mHPV, infectious bronchitis virus
induces the formation of autophagosomes when inhibited through
the silencing of Atg5 [105]. However, this phenomenon did not
alter the replication of the virus, which suggests that this protein
is not essential for autophagosome induction by this virus [105].
It has been shown that autophagy can be inhibited in epithelial
cells during influenza infection [8]. Autophagosome fusion with
acidified proteolytic lysosomes in influenza-infected human
epithelial cell lines is significantly inhibited [8], thereby influenza
may exploit autophagy as a mechanism to avoid degradation by
lysosomes. The M2 influenza protein, which plays important roles
in several steps of influenza virus infection, which works as a
E. Rey-Jurado et al. / FEBS Letters 589 (2015) 3461–3470 3467proton channel and has been shown to be key for the modulation
of autophagy in infected cells [8,39]. While M2-transfected cells
showed autophagosome accumulation, calls transfected with other
influenza A virus proteins did not show alterations of the autop-
hagy pathways [39]. In addition, M2 has been shown to interact
with LC3 and promotes its LC3 redistribution to the plasma
membrane [39]. Along these lines, different compounds with
anti-influenza activity have been shown to either block or modu-
late autophagy, by altering host-virus protein interactions
[40,106]. Indeed, the replication of influenza within the
autophagosome may be reduced by blocking the induction of
autophagy. Baicalin, a flavonoid compound with antiviral proper-
ties, shows inhibitory activity over autophagy by inhibiting mTOR
signaling and Atg5-Atg12 during influenza infection [106].
Interestingly, the same group showed that simvastatins can also
promote the accumulation of LC3-II levels that could favor
autophagosome building up [40].
HIV has also received significant attention because of its capac-
ity to modulate autophagy in a cell type-dependent manner [80].
HIV modulates autophagy in adipocytes, CD4+ T cells, macrophages
and DCs, by different mechanisms depending on the cell type
[69,107,108]. HIV has been shown to trigger autophagy in CD4+ T
cells, leading to higher LC3-II, Atg5 and Beclin-1 [9,108]. In
contrast, HIV-1 infection in DCs leads to the loss of LC3-II accumu-
lation, which interferes with autophagosome-mediated degrada-
tion of the virus [69].
Autophagy in neurons is also of particular interest. Overexpres-
sion of Beclin-1 in neurons from neonatal mice showed protection
against a lethal Sindbis virus infection [58]. Atg5 and Atg7 have
also been shown to trigger autophagy in Sindbis virus-infected
neurons and to prevent virus-induced cell death in vivo and
in vitro when performing studies using knockout techniques [59].
Interestingly, Atg5 disruption in neurons did not vary viral titers
in the central nervous system, suggesting that Atg5 does not play
an essential role in the clearance of Sindbis virus, at least in these
cells [59]. On the other hand, simian immunodeficiency virus type
I-infected microglia inhibits neuronal autophagy, thereby decreas-
ing neuron survival [109]. An association between autophagy and
apoptosis and cell death derives from the interaction of Beclin-1
with the major anti-apoptotic B-cell lymphoma (Bcl) family pro-
tein [110]. These observations suggest that autophagy has been
shown to be critical for blocking cell death in virus-infected neu-
rons. Because autophagy can be considered as a process opposite
to cell death or apoptosis in cells, the promotion of this process
may provide an advantageous environment for viruses to replicate
and spread onto neighboring cells.
A role for autophagy components in immune cells, such as
invariant natural killer T (NKT) cells has also been evidenced.
Indeed, deletion of Atg7 has been reported to impair NKT cell
development in a T cell-intrinsic manner [83]. These findings sug-
gest that autophagy may play a role in the development and func-
tion of these cells during antiviral responses. Similar to DCs,
different populations of NKT cells have been shown to contribute
to the immune response against HSV-1 [111], HSV-2 [112],
encephalomyocarditis virus [113] and hRSV [114]. Thus, it is likely
that autophagy could modulate the function of NKT cells during
anti-viral immune responses against viral infections. Based on
reports that support a role for autophagy during the replication
and life cycle of certain viruses, the use of specific autophagy-
inducing agents has been proposed as a strategy for treating or
preventing several infectious diseases [102].
5.4. Autophagy and virus components needed for replication
A role for autophagy in viral infection with HPV has also
acquired particular attention. HPV induces autophagy and exploitsthe components of this cellular process for genome replication and
viral envelope formation. However, the mechanisms involved in
the interactions between autophagy components and virus deter-
minants remains controversial [115,116]. For instance, HPV utilizes
some of the host’s autophagy machinery molecules to release its
naked viral capsids, requiring for example Rab33B, a GTPase that
participates in autophagosome formation via the Atg5-Atg12-
ATG16L complex [117]. Nevertheless, the suppression of conven-
tional autophagy processes using chemical inhibitors, such as
3-MA did not produce any effect on capsid release, indicating that
the virus does not require an intact autophagosome to release
capsids [117].
6. Concluding remarks
Autophagy components, which include autophagy-related pro-
teins and adaptors have been demonstrated to interact with
numerous components belonging to innate and adaptive immune
responses. However, whether autophagy is positive or negative
for viral infection and pathology remains to be elucidated. Indeed,
in the context of an infection, autophagy may act as a double edge
sword. While autophagy may help to eliminate pathogens, it can
also could work as a reservoir for pathogen growth and escape
from apoptosis or cell death. However, consistent with an impor-
tant role for autophagy during viral infections, viruses have
evolved different mechanisms to counteract this cellular process.
Because of its involvement during viral infections, autophagy is
actively being explored as a cellular target for the development
of vaccines and therapies for preventing virus spread or dissemina-
tion [81,82,118]. Undoubtedly, further research is required to
understand the interactions occurring between components of
autophagy and the immune system. This knowledge will con-
tribute explaining as to how viruses counteract this defensive host
system for their own benefit and open new possibilities to improve
antiviral therapeutics and vaccines.
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